Jane Street
DTIL icon

Jane Street’s Precision BioSciences DTIL Stock Holding History

Jane Street’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-680
Closed -$170K – 9177
2020
Q4 		$170K Buy
+680
New +$167K ﹤0.01% 7028

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Jane Street's DTIL Position: Q1 2026 in Review

Jane Street opened a new position in Precision BioSciences (DTIL) in Q1 2026: 18,993 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #10628 among its holdings. This is a return to the name: Jane Street previously reported a position in DTIL as recently as Q4 2024.

Jane Street first reported a position in DTIL in Q4 2020 and has held it in 9 quarters since. The position peaked at $665K in Q2 2021. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • Jane Street held 18,993 shares of Precision BioSciences worth $104K as of Q1 2026.
  • Precision BioSciences was a new Jane Street position in Q1 2026.
  • Precision BioSciences made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10628 holding.
  • Jane Street first reported a position in Precision BioSciences in Q4 2020 and has held it in 9 quarters since.
  • Jane Street's Precision BioSciences position peaked at $665K in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.